Pandora, Gap Post R...
Health Care: Health Services
Derma Sciences Inc. (DSCI: NASDAQ)
$14.01 0.20 | 1.45%
05/24/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 41.62M | 17.11M | 404.22K | 243.52K |
| Receivables | 7.09M | 6.27M | 5.44M | 3.37M |
| Inventories | 13.67M | 10.53M | 12.50M | 11.49M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 69.31M | 41.23M | 18.95M | 15.56M |
| Property, Plant & Equipment, Gross | 10.20M | 9.38M | 8.72M | 7.76M |
| Accumulated Depreciation & Depletion | 6.90M | 5.89M | 5.11M | 4.02M |
| Property, Plant & Equipment, Net | 3.30M | 3.49M | 3.61M | 3.74M |
| Intangibles | 17.13M | 6.40M | 6.97M | 3.99M |
| Other Non-Current Assets | 639.21K | 378.82K | 316.86K | 2.88M |
| Total Non-Current Assets | 34.53M | 17.39M | 18.02M | 17.74M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 103.84M | 58.62M | 36.97M | 33.30M |
| Accounts Payable | 3.99M | 4.00M | 3.78M | 3.36M |
| Short Term Debt | 0.00 | 0.00 | 3.08M | 4.07M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 8.13M | 6.38M | 9.01M | 8.77M |
| Long Term Debt | 268.52K | 0.00 | 0.00 | 2.31M |
| Deferred Income Taxes | 1.74M | 1.15M | 1.07M | 355.35K |
| Other Non-Current Liabilities | 0.00 | 252.68K | 211.58K | 96.56K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.00M | 1.40M | 1.28M | 2.76M |
| Total Liabilities | 10.13M | 7.78M | 10.29M | 11.53M |
| Preferred Stock Equity | 733.00 | 733.00 | 2.85K | 2.85K |
| Common Stock Equity | 93.71M | 50.85M | 26.68M | 21.77M |
| Common Par | 165.25K | 105.78K | 65.63K | 50.40K |
| Additional Paid In Capital | 132.16M | 77.37M | 48.80M | 41.22M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -40.21M | -28.14M | -23.80M | -20.81M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 1.59M | 1.50M | 1.60M | 1.30M |
| Total Capitalization | 93.98M | 50.85M | 26.68M | 24.08M |
| Total Equity | 93.71M | 50.85M | 26.68M | 21.77M |
| Total Liabilities & Stock Equity | 103.84M | 58.62M | 36.97M | 33.30M |
| Total Common Shares Outstanding | 16.52M | 10.58M | 6.56M | 5.04M |
| Preferred Shares | 73.33K | 73.33K | 284.84K | 285.05K |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 12.49M | 8.78M | 6.34M | 5.03M |
| Diluted Weighted Shares Outstanding | 12.49M | 8.78M | 6.34M | 5.03M |
| Number of Employees | 237 | 212 | 195 | 163 |
| Number of Part-Time Employees | 7 | 2 | 0 | 11 |
Portfolios with DSCI
- Portfolio NameUser Type
- UserMedical devices M&A
- Contributor3 Small-Cap Stocks on Insid...
- Contributor10 Biotech Stocks Loved and...
- Contributor11 Biotech Stocks Loved or ...
- UserTest Drive
- Contributor10 Cheap Biotech Stocks Tha...
- Contributor5 Health Care Stocks With U...
- ContributorBarron's Insider Purchases ...
- UserPINOCH
Latest DSCI Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- 3 Small-Cap Stocks on Insiders' Radar 11.18.11 | 01:11 pm
- Insiders Trading BBBY, ENTG, DSCI, CHKM 10.20.11 | 10:10 am
- 11 Biotech Stocks Loved or Hated by Hedge Funds 08.17.11 | 06:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- Insiders Trading NS, TZOO, DSCI, CRR 05.28.11 | 03:05 pm
- Biotech Stock Mailbag: Fibrocell Science 05.27.11 | 06:05 am
- Derma Stock Soars (DSCI) 05.25.11 | 10:05 am
- Derma Sciences: Drug Extends Wound Healing 05.25.11 | 07:05 am
Press Releases for DSCI
- Derma Sciences Announces Timing For Fourth Quarter Conference Call And 2012 Form 10-K Filing - Business Wire 03.15.13 | 04:03 pm
- Derma Sciences To Present At The 25th Annual ROTH Conference - Business Wire 03.14.13 | 12:03 pm
- Derma Sciences Initiates Enrollment In DSC127 Phase 3 Trial For Healing Diabetic Foot Ulcers - Business Wire 02.06.13 | 08:02 am
- Derma Sciences Closes $36.4 Million Underwritten Public Offering Of Common Stock, Including Full Over-Allotment - Business Wire 12.11.12 | 05:12 pm
- Derma Sciences Announces Pricing Of Underwritten Public Offering Of Common Stock - Business Wire 12.06.12 | 09:12 am
- Derma Sciences Announces Commencement Of Public Offering Of Common Stock - Business Wire 12.05.12 | 04:12 pm
- Derma Sciences To Present At Two Upcoming Conferences - Business Wire 11.30.12 | 02:11 pm
- Derma Sciences To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.20.12 | 08:11 am
- Derma Sciences To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 10:11 am
- Derma Sciences Reports Third Quarter 2012 Financial Results - Business Wire 11.12.12 | 07:11 am
Partner Headlines for DSCI
- Pre-Market Earnings Report for May 16, 2013 : WMT, KSS, FLO, CAE, BRC, PBH, IMOS, DANG, DSCI, SOL, CTCH - NASDAQ 05.15.13 | 08:05 pm
- Pre-Market Earnings Report for April 1, 2013 : CALM, DSCI - NASDAQ 03.28.13 | 08:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 12.04.12 | 09:12 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.29.12 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.20.12 | 09:11 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 09.12.11 | 09:09 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.31.11 | 09:03 am
